Clinical Trials
3 trialsNCT02204982 2023-09-28
DYNAMO + R
SecuraBio
Phase 3 Terminated
NCT02292225 2023-02-27
Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)
SecuraBio
Phase 1 Terminated
NCT03074825 2019-07-24
Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma
Chipscreen Biosciences, Ltd.
Phase 1 Terminated